Your search relates to more than one category
PR News Wire (Free subscription) | yesterday
SAN DIEGO, Dec. 8, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Deutsche Bank Biotech Boston Confab on Tuesday, December 15, 2009 at 1:35 p.m. ET / 10:35 a.m. PT in Boston. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.
Red Orbit (Free subscription) | yesterday
SAN DIEGO, Dec. 8, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Deutsche Bank Biotech Boston Confab on Tuesday, December 15, 2009 at 1:35 p.m. ET / 10:35 a.m. PT in Boston. Daniel M.
GuruFocus Updates (Free subscription) | 11/05/2009
By 10qk. Amylin Pharmaceuticals Inc. ( AMLN ) filed Quarterly Report for the period ended 2009-09-30. Read more » »
PR News Wire (Free subscription) | 11/05/2009
SAN DIEGO, Nov. 5, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the 18th Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, November 11, 2009 at 10:00 a.m. PT / 1:00 p.m. ET. Mark Foletta, senior vice president of finance and chief financial officer at Amylin Pharmaceuticals, will be providing a corporate...
Red Orbit (Free subscription) | 11/05/2009
SAN DIEGO, Nov. 5, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the 18th Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, November 11, 2009 at 10:00 a.m. PT / 1:00 p.m. ET.
Medical News Today (Free subscription) | 11/03/2009
Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) issued the following statement in response to the U.S. Food and Drug Administration (FDA) update on BYETTA® (exenatide) injection. "The FDA update issued today aligns with the BYETTA label approved last week. The current label reflects our understanding of post-marketing reports of renal events...
Business Wire (Free subscription) | 11/02/2009
NEWARK, Del.--(BUSINESS WIRE)--PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to execute on the business development level to bring value to shareholders. Some of our past picks had soared over 200%. To view some of our profiled stocks, please visit our website at...
PR News Wire (Free subscription) | 11/02/2009
SAN DIEGO and INDIANAPOLIS, Nov. 2, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today issued the following statement in response to the U.S. Food and Drug Administration (FDA) update on BYETTA® (exenatide) injection.
PR News Wire (Free subscription) | 11/02/2009
SAN DIEGO and OSAKA, Japan, Nov. 1, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications....
Red Orbit (Free subscription) | 11/01/2009
SAN DIEGO and OSAKA, Japan, Nov. 1, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc.
Star Tribune (Free subscription) | 11/02/2009
NEW YORK - Amylin Pharmaceuticals Inc. says it could potentially receive more than $1 billion from a partnership with Japan's Takeda Pharmaceutical Co. on potential obesity treatments.Amylin, based in San Diego, said late Sunday it will receive $75 million upfront from Takeda and said future payments for development and achieving commercial milestones could top $1 billion.The deal includes...
Market Wire (Free subscription) | 11/27/2009
... us their updated feedback regarding the current market activity and position on US Airways Group Inc. (NYSE: LCC), AMR Corporation (NYSE: AMR), Delta Air Lines (NYSE: DAL), Amylin Pharmaceuticals Inc. (NASDAQ: AMLN), Illumina Inc.
24/7 Wall St. (Free subscription) | 11/24/2009
These are this morning’s top day trader and active trader alerts seen in early pre-market trading. We have more details and analysis on each stock available in links over at VSInvestor.com: Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) was up 10% on an analyst upgrade by Barclays. Brocade Communications Systems Inc. (NASDAQ: BRCD) was down 2% after earnings. TiVo Inc....
Stock Market Analysis (Free subscription) | 11/24/2009
Below is a list of some of the largest stock gainers and losers so far in pre market for November 24, 2009. Check out my Hot Stocks to Watch page for the latest updates. Pre Market Stock Gainers - 11/24/09 NexMed Inc. (NEXM) - Form 8-K for NEXMED INC AEterna Zentaris Inc. (AEZS) - AEterna Zentaris Announces Positive Results for Phase 2 Study Amylin Pharmaceuticals, Inc....
Volume Spike Investor (Free subscription) | 11/24/2009
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) was raised to overweight this morning by BGarclays as seen in our top ten analyst calls. Apparently, shares are taking it to heart immediately. At 8:18 AM EST we have seen 50,000 shares trade hands, yet shares are up over 10% at $13.80 after a $12.47 close. The average volume [...]
